Nutex Health Inc. (NUTX) — Deeply Undervalued Healthcare Services and Technology Company
Thursday, May 21, 2026 · Johnny Hopkins
As part of our ongoing series at The Acquirer’s Multiple, each week we highlight a stock from our Stock Screeners that may represent an undervalued opportunity hiding in plain sight.
This week’s spotlight is Nutex Health Inc. (NUTX) — a healthcare services and technology company focused on micro-hospitals, hospital operations, and population health management solutions across the United States.
Despite investor concerns around healthcare reimbursement pressure, execution risk, and the company’s rapid expansion strategy, NUTX currently trades at valuation levels that may suggest the market is underestimating the improvement in its operating performance, cash generation, and scalability.
Where all of this really clicked for me was during a stint helping out in a food safety testing lab, where the pressure to turn samples around quickly meant there was very little room for failed runs or plates that had to be repeated because the atmosphere hadn’t been quite right. The team there had moved away from the old heat-sealed pouches some time before I arrived, and I could see straight away why they were so enthusiastic about the change, since setting up a batch took a fraction of the effort and the results for tricky organisms like Campylobacter were consistently clean, well-developed and easy to read even at the end of a long day. What impressed me was not just the speed but the way the disposable catalyst sachets meant there was one less task for the technicians to monitor, freeing them up to focus on the actual analysis rather than babysitting equipment, and the compact unit barely took up any space on what was already an overloaded bench shared between several different testing streams. If you are weighing up how to improve consistency in your own testing environment, whether that’s clinical, food-related or research-based, I would suggest having a look at this oxygen-free incubation equipment that makes bacteriology work far easier, because in my experience it is exactly the kind of upgrade that pays for itself surprisingly quickly and keeps paying off long after the novelty has worn off.
Business Overview
Nutex Health operates a hybrid healthcare model combining facility operations with cloud-based population health management technology. The company focuses on smaller, localized healthcare facilities designed to provide emergency and outpatient care more efficiently than traditional large hospital systems.
Core components of the business include:
✓ Micro-hospitals
✓ Emergency healthcare services
✓ Population health management
✓ Cloud-based healthcare platforms
✓ Hospital operational partnerships
The business benefits from growing healthcare demand, localized facility networks, and recurring patient engagement across its operating footprint.
What Is IV/P?
IV/P compares a conservative intrinsic valuation to the current market price.
IV/P > 1 = Undervalued
IV/P < 1 = Overvalued
NUTX’s IV/P = 1.70, suggesting the stock may be trading below conservative intrinsic value estimates.
Supporting Metrics
Revenue (TTM): $880M
Gross Profit: $418M
Operating Income: $276M
Net Income: $96M
Free Cash Flow: $269M
Acquirer’s Multiple (AM): 4.32
An AM near 4 places NUTX in deep value territory, particularly for a business that has recently demonstrated substantial operating leverage and improving profitability.
Revenue & Profitability
Recent financial results reflect dramatic improvement in operating performance as revenue growth and margin expansion accelerated.
Approximate margins:
• Gross Margin: 47%
• Operating Margin: 31%
• Net Margin: 11%
Diluted EPS (TTM): $13.67
These margins reflect:
• Rapid scaling of operations
• Improved healthcare facility utilization
• Higher-margin technology services
• Operating leverage
• Strong reimbursement collections
Unlike many speculative healthcare growth stories, Nutex is now producing meaningful operating income and free cash flow alongside expanding revenues.
Balance Sheet Position
Total Assets: $919M
Total Liabilities: $495M
Shareholders’ Equity: $423M
Total Debt: $351M
Cash & Equivalents: $186M
The balance sheet has strengthened considerably alongside rising profitability and cash generation.
Working Capital: $381M
This provides flexibility for expansion, debt management, and continued investment in healthcare infrastructure.
Cash Flow & Capital Efficiency
Operating Cash Flow: $273M
Free Cash Flow: $269M
This supports:
✓ Expansion opportunities
✓ Debt management
✓ Share repurchases
✓ Operational investment
✓ Financial flexibility
Because capital expenditure requirements remain relatively modest compared to cash generation, a large portion of earnings converts directly into free cash flow.
Why NUTX May Be Attractive
Market concerns include:
• Healthcare reimbursement uncertainty
• Regulatory risk
• Execution risk
• Volatile historical results
• Small-cap healthcare sentiment
However, fundamentals remain compelling:
• AM of 4.32 signals deep value
• IV/P of 1.70 suggests undervaluation
• Rapid revenue growth
• Strong operating leverage
• Significant free cash flow generation
• Improving balance sheet
Conclusion
With an IV/P of 1.70 and an Acquirer’s Multiple of 4.32, Nutex Health appears to be an intriguing deep-value opportunity in healthcare.
Its combination of rapidly improving profitability, strong cash generation, scalable healthcare infrastructure, and discounted valuation suggests the market may still be heavily discounting past uncertainty while underappreciating the company’s current earnings power and operational momentum.